These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21810389)

  • 21. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End stage renal disease caused by thromboangiitis obliterans: a case report.
    Yun HJ; Kim DI; Lee KH; Lim SJ; Hwang WM; Yun SR; Yoon SH
    J Med Case Rep; 2015 Aug; 9():174. PubMed ID: 26286269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
    Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
    Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
    [No Abstract]   [Full Text] [Related]  

  • 24. A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans.
    Shima N; Akiyama Y; Yamamoto S; Kokuzawa A; Nagatani K; Iwamoto M; Matsubara D; Kawai S; Sato K; Minota S
    Intern Med; 2020 Feb; 59(3):439-443. PubMed ID: 31588083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboangiitis obliterans with inaugural rheumatic manifestations. A report of three cases.
    Lambotte O; Chazerain P; Vinciguerra C; Meyer O; Ziza JM
    Rev Rhum Engl Ed; 1997 May; 64(5):334-8. PubMed ID: 9190007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors.
    Abeles AM; Nicolescu M; Pinchover Z; Abeles M
    Vascular; 2014 Aug; 22(4):313-6. PubMed ID: 24000082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left Carotid Artery Thrombosis Due to Thromboangiitis Obliterans.
    Bourgeau ME; Key PG; Chou J; Prahlow JA
    Am J Forensic Med Pathol; 2021 Sep; 42(3):297-300. PubMed ID: 33346979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
    Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
    J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral vein thrombosis in a case with thromboangiitis obliterans.
    Bischof F; Kuntz R; Melms A; Fetter M
    Cerebrovasc Dis; 1999; 9(5):295-7. PubMed ID: 10473913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrarenal arterial stenosis in a patient with thromboangiitis obliterans.
    Goktas S; Bedir S; Bozlar U; Ilica AT; Seckin B
    Int J Urol; 2006 Sep; 13(9):1243-4. PubMed ID: 16984562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
    Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E
    J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of smokeless tobacco for cigarettes in Buerger's disease does not prevent limb loss.
    Lawrence PF; Lund OI; Jimenez JC; Muttalib R
    J Vasc Surg; 2008 Jul; 48(1):210-2. PubMed ID: 18589234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buerger's disease and pulmonary hypertension: a rare association?
    Abi-Saleh B; Chirculescu C; Eggleston KL; Takubo T; Byrd RP; Roy TM
    Tenn Med; 2005 Jan; 98(1):37-8, 42. PubMed ID: 15696819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reappraisal of thromboangiitis obliterans--a pathological contribution.
    Kurata A; Schulz A; Franke FE
    Verh Dtsch Ges Pathol; 2004; 88():231-6. PubMed ID: 16892557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
    Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
    J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoadsorption in thrombangiitis obliterans: a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care].
    Klein-Weigel PF; Köning C; Härtwig A; Krüger K; Gutsche-Petrak B; Dreusicke S; Thieme U; Enke-Melzer K; Urbach B; Kron J
    Zentralbl Chir; 2012 Oct; 137(5):460-5. PubMed ID: 23136105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman.
    Lopalco G; Iannone F; Rigante D; Vitale A; Mancini ME; Covelli M; Lapadula G; Cantarini L
    Reumatismo; 2015 Jun; 67(1):17-20. PubMed ID: 26150270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Buerger's disease].
    Chochola M; Márová K; Linhart A
    Cas Lek Cesk; 2006; 145(5):358-62. PubMed ID: 16755770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thromboangiitis obliterans: notions for practice].
    Calanca L; Alatri A; Krieger C; Corpataux JM; Mazzolai L
    Rev Med Suisse; 2017 Dec; 13(586):2129-2133. PubMed ID: 29211372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
    Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
    Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.